HomeONCY • NASDAQ
add
Oncolytics Biotech Inc
Nakaraang pagsara
$0.91
Sakop ng araw
$0.90 - $0.98
Sakop ng taon
$0.33 - $1.51
Market cap
93.73M USD
Average na Volume
851.59K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (CAD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | — | — |
Gastos sa pagpapatakbo | 13.84M | 39.81% |
Net na kita | -14.40M | -50.90% |
Net profit margin | — | — |
Kita sa bawat share | -0.14 | -16.67% |
EBITDA | -13.82M | -40.08% |
Aktuwal na % ng binabayarang buwis | 1.72% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (CAD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 12.35M | -36.97% |
Kabuuang asset | 15.06M | -37.94% |
Kabuuang sagutin | 14.94M | -1.73% |
Kabuuang equity | 115.00K | — |
Natitirang share | 106.15M | — |
Presyo para makapag-book | ∞ | — |
Return on assets | -197.54% | — |
Return on capital | -872.97% | — |
Cash Flow
Net change in cash
| (CAD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -14.40M | -50.90% |
Cash mula sa mga operasyon | -6.65M | -37.64% |
Cash mula sa pag-invest | -7.00K | 78.12% |
Cash mula sa financing | 4.14M | 2,491.91% |
Net change in cash | -2.27M | 56.70% |
Malayang cash flow | -765.00K | 55.05% |
Tungkol
Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that: induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses. Wikipedia
Itinatag
1998
Headquarters
Website
Mga Empleyado
28
